Zimmermann, Gregor S.;
Fingerle, Alexander A.;
Müller-Leisse, Christina;
Gassert, Felix;
von Schacky, Claudio E.;
Ibrahim, Tareq;
Laugwitz, Karl-Ludwig;
Geisler, Fabian;
Spinner, Christoph;
Haller, Bernhard;
Makowski, Markus R.;
Nadjiri, Jonathan
Coronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: An analysis of a hospitalized German cohort
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Coronary calcium scoring assessed on native screening chest CT imaging as predictor for outcome in COVID-19: An analysis of a hospitalized German cohort
Contributor:
Zimmermann, Gregor S.;
Fingerle, Alexander A.;
Müller-Leisse, Christina;
Gassert, Felix;
von Schacky, Claudio E.;
Ibrahim, Tareq;
Laugwitz, Karl-Ludwig;
Geisler, Fabian;
Spinner, Christoph;
Haller, Bernhard;
Makowski, Markus R.;
Nadjiri, Jonathan
Published:
Public Library of Science (PLoS), 2020
Published in:
PLOS ONE, 15 (2020) 12, Seite e0244707
Language:
English
DOI:
10.1371/journal.pone.0244707
ISSN:
1932-6203
Origination:
Footnote:
Description:
BackgroundSince the outbreak of the COVID-19 pandemic, a number of risk factors for a poor outcome have been identified. Thereby, cardiovascular comorbidity has a major impact on mortality. We investigated whether coronary calcification as a marker for coronary artery disease (CAD) is appropriate for risk prediction in COVID-19.MethodsHospitalized patients with COVID-19 (n = 109) were analyzed regarding clinical outcome after native computed tomography (CT) imaging for COVID-19 screening. CAC (coronary calcium score) and clinical outcome (need for intensive care treatment or death) data were calculated following a standardized protocol. We defined three endpoints: critical COVID-19 and transfer to ICU, fatal COVID-19 and death, composite endpoint critical and fatal COVID-19, a composite of ICU treatment and death. We evaluated the association of clinical outcome with the CAC. Patients were dichotomized by the median of CAC. Hazard ratios and odds ratios were calculated for the events death or ICU or a composite of death and ICU.ResultsWe observed significantly more events for patients with CAC above the group’s median of 31 for critical outcome (HR: 1.97[1.09,3.57], p = 0.026), for fatal outcome (HR: 4.95[1.07,22.9], p = 0.041) and the composite endpoint (HR: 2.31[1.28,4.17], p = 0.0056. Also, odds ratio was significantly increased for critical outcome (OR: 3.01 [1.37, 6.61], p = 0.01) and for fatal outcome (OR: 5.3 [1.09, 25.8], p = 0.02).ConclusionThe results indicate a significant association between CAC and clinical outcome in COVID-19. Our data therefore suggest that CAC might be useful in risk prediction in patients with COVID-19.